Zacks gives SCA ‘sell’ rating — 5 notes

Zacks analysts lowered Surgical Care Affiliates form a “hold” to a “sell” rating, according to Petro Global News.

Advertisement

Here are five notes:

1. Recently, Barclays increased their SCA price objective from $42 to $45.

2. JP Morgan & Chase has a “neutral” rating on SCA shares.

3. On Sept. 19, SCA shares traded down 8.22 percent.

4. SCA has a 50-day moving average of $34.42.

5. The 200-day moving average is $37.02.

More articles on surgery centers:
Dr. Craig Amshel opens surgery center to expand healthcare access to Floridians — 4 key points
Orange Regional Medical Center opens ASC — 4 notes
Yearlong CON battle over Green Mountain Surgical Center continues — 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.